M. D. Anderson Cancer Center - News Releases This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Immatics and MD Anderson announce launch of Immatics US, Inc., to develop multiple T-cell and TCR-based adoptive cellular therapies
Immatics Biotechnologies GmbH (Immatics) and MD Anderson Cancer Center announced today the launch of Immatics US, Inc., a new company aiming at becoming a global leader in adoptive cellular therapies (ACT) for the treatment of a range of tumor types. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 26, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson to host evening fun run supporting skin cancer research
Runners and walkers will hit the streets for the eighth annual AIM for the CURE Melanoma Walk and Fun Run to raise funds and awareness for the disease. The event on Sept. 26 at 6 p.m. is co-hosted by MD Anderson Cancer Center and The AIM at Melanoma Foundation. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 26, 2015 Category: Cancer & Oncology Source Type: news

Generic heart medication shown to prolong ovarian cancer patients' survival
In a first-of-its-kind study, researchers demonstrate a benefit in overall survival among epithelial ovarian cancer (EOC) patients receiving generic heart medications known as beta-blockers.  (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 23, 2015 Category: Cancer & Oncology Source Type: news

UTMB, MD Anderson to collaborate on League City campus
The University of Texas Medical Branch at Galveston and MD Anderson Cancer Center have signed a first-ever clinical collaboration agreement, which today was approved by The University of Texas System Board of Regents. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 20, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson to build new outpatient center in West Houston
With the approval of The University of Texas System Board of Regents today, MD Anderson Cancer Center is one step closer to developing and building its own outpatient diagnostic and treatment center to better serve the growing communities of West Houston and beyond. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 20, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson study reveals new insight into tumor progression
Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 17, 2015 Category: Cancer & Oncology Source Type: news

Merck and MD Anderson announce immuno-oncology research collaboration in solid tumors
Merck and The University of Texas MD Anderson Cancer Center announced a strategic clinical research collaboration to evaluate Merck's anti-PD-1 therapy, KEYTRUDA (pembrolizumab), in combination with other treatments, such as chemotherapy, radiation therapy and/or novel anti-tumor medicines. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 13, 2015 Category: Cancer & Oncology Source Type: news

Helping preschoolers deploy 'superpowers' against sunburn
Five globe-trotting, sun-blocking superheroes teach preschoolers about lifelong sun safety in a new curriculum available this summer based on research at The University of Texas MD Anderson Cancer Center. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 12, 2015 Category: Cancer & Oncology Source Type: news

Poor survival among colorectal cancer patients tied to biomarker CSN6
A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at  MD Anderson Cancer Center. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 10, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson names Valerae O. Lewis, M.D., chair of Orthopaedic Oncology
Internationally respected surgeon, Valerae O. Lewis, M.D., has been named chair of Orthopaedic Oncology at MD Anderson Cancer Center.  (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 10, 2015 Category: Cancer & Oncology Source Type: news

Shorter course of radiation therapy associated with less toxicity
Women who receive a shorter course of whole breast radiation therapy for early stage disease experience less toxicity and improved quality of life compared to those who undergo a longer course of treatment, researchers report from The University of Texas MD Anderson Cancer Center. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 6, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson study reveals new insight into DNA Repair
DNA double-strand breaks (DSBs) are the worst possible form of genetic malfunction that can cause cancer and resistance to therapy. New information published this week reveals more about why this occurs and how these breaks can be repaired. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 3, 2015 Category: Cancer & Oncology Source Type: news

Potential new therapy approaches to reverse kidney damage identified
Adults who are worried or terrified sometimes curl up into a fetal position. Likewise, adult cells that are injured, including genetic injury leading to cancer, initiate a process that was present during embryonic development. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - August 3, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson named as one of two Genome Characterization Centers
The University of Texas MD Anderson Cancer Center has been named a site for one of two new Genome Characterization Centers (GCC) funded through the National Cancer Institute (NCI). (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - July 22, 2015 Category: Cancer & Oncology Source Type: news

MD Anderson presents Making Cancer History seminar in Santa Fe
The University of Texas MD Anderson Cancer Center will host a Making Cancer History® seminar in Santa Fe, 11:30 a.m. to 1 p.m. on Thursday, Aug. 6 at the Inn and Spa at Loretto, 211 Old Santa Fe Trail. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - July 22, 2015 Category: Cancer & Oncology Source Type: news